CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma

Documenti analoghi

• Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma
  di: Larissa Haertle, et al.
  Pubblicazione: (2024)
• Interferon gamma‐mediated prevention of tumor progression in a mouse model of multiple myeloma
  di: Zoltán Kellermayer, et al.
  Pubblicazione: (2024)
• Expression profile of Bcl‐2 family proteins in newly diagnosed multiple myeloma patients
  di: Cristina De Ramón, et al.
  Pubblicazione: (2024)
• The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma
  di: Anna de Daniel, et al.
  Pubblicazione: (2024)
• Navigating the evolving management of smoldering multiple myeloma
  di: M. Bakri Hammami, et al.
  Pubblicazione: (2026)